Novanta Balance Sheet Health
Financial Health criteria checks 3/6
Novanta has a total shareholder equity of $745.7M and total debt of $416.6M, which brings its debt-to-equity ratio to 55.9%. Its total assets and total liabilities are $1.4B and $642.8M respectively. Novanta's EBIT is $126.5M making its interest coverage ratio 4. It has cash and short-term investments of $114.0M.
Key information
55.9%
Debt to equity ratio
US$416.64m
Debt
| Interest coverage ratio | 4x |
| Cash | US$113.99m |
| Equity | US$745.70m |
| Total liabilities | US$642.81m |
| Total assets | US$1.39b |
Recent financial health updates
Is Novanta (NASDAQ:NOVT) A Risky Investment?
Jan 24
Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?
May 30Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?
Feb 05Novanta (NASDAQ:NOVT) Seems To Use Debt Quite Sensibly
Sep 21These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Reasonably Well
May 16These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Safely
Feb 12Recent updates
Should You Think About Buying Novanta Inc. (NASDAQ:NOVT) Now?
Apr 19Novanta: A Trusted Yet Premium Technology Partner
Apr 06Novanta Inc.'s (NASDAQ:NOVT) Stock Retreats 27% But Earnings Haven't Escaped The Attention Of Investors
Apr 05There May Be Some Bright Spots In Novanta's (NASDAQ:NOVT) Earnings
Mar 05Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger
Feb 09Is Novanta (NASDAQ:NOVT) A Risky Investment?
Jan 24Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$151?
Jan 07Novanta: Delayed Recovery And Prolonged Struggles Ahead, Downgrade To Sell
Jan 01Novanta Inc.'s (NASDAQ:NOVT) Business Is Yet to Catch Up With Its Share Price
Dec 21Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital
Oct 15What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S
Sep 12Novanta Inc.: Overpriced In A Weak Demand Market. Here's Why It's A Hold
Sep 02
Innovative Medical Devices And Tactical Acquisitions Poised To Accelerate Company Growth
Aug 28 Focusing on medical devices with new products might significantly boost future revenue through innovation, aiming for notable revenue from new launches by 2025.Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?
Aug 24Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price
Aug 02Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively
Jun 22Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?
May 30Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)
May 08Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger
Feb 24Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?
Feb 05Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely
Dec 29Why Novanta Inc. (NASDAQ:NOVT) Could Be Worth Watching
Nov 20Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching
Nov 01Does This Valuation Of Novanta Inc. (NASDAQ:NOVT) Imply Investors Are Overpaying?
Oct 19Novanta (NASDAQ:NOVT) Seems To Use Debt Quite Sensibly
Sep 21Return Trends At Novanta (NASDAQ:NOVT) Aren't Appealing
Sep 06What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?
Aug 19Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching
Jul 16Slowing Rates Of Return At Novanta (NASDAQ:NOVT) Leave Little Room For Excitement
Jun 06These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Reasonably Well
May 16Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$156?
Apr 13Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching
Mar 29Investors Met With Slowing Returns on Capital At Novanta (NASDAQ:NOVT)
Feb 27These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Safely
Feb 12Is Novanta Inc. (NASDAQ:NOVT) Potentially Undervalued?
Jan 12We Ran A Stock Scan For Earnings Growth And Novanta (NASDAQ:NOVT) Passed With Ease
Dec 28Is Novanta (NASDAQ:NOVT) Using Too Much Debt?
Nov 02Financial Position Analysis
Short Term Liabilities: NOVT's short term assets ($433.6M) exceed its short term liabilities ($167.8M).
Long Term Liabilities: NOVT's short term assets ($433.6M) do not cover its long term liabilities ($475.0M).
Debt to Equity History and Analysis
Debt Level: NOVT's net debt to equity ratio (40.6%) is considered high.
Reducing Debt: NOVT's debt to equity ratio has increased from 52.8% to 55.9% over the past 5 years.
Debt Coverage: NOVT's debt is well covered by operating cash flow (38%).
Interest Coverage: NOVT's interest payments on its debt are well covered by EBIT (4x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/21 07:21 |
| End of Day Share Price | 2025/04/17 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Novanta Inc. is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Mason | Baird |
| Ishan Majumdar | Baptista Research |
| Andrew Buscaglia | Berenberg |